<p>Bone marrow derived DCs were generated and cultured overnight in media containing (A) no maturation stimulus, (B) CpG ODN 1826 (10 μM), (C) LPS (10 ng/ml), or (D) imiquimod acetate (25 μM), prior to pulsing with gp33–41, gp276–286, and gp61–80 peptides and tail vein infusion to RIP-gp mice at 2×10<sup>6</sup> DC/mouse. Blood glucose levels were followed after vaccination. Each line represents an individual mouse. (E) Quantification of diabetes incidence following transfer of DC as in (A-D) for 10–20 mice per group. (F) Quantification of the degree of CD8<sup>+</sup> and CD4<sup>+</sup> cell infiltration in pancreatic histology 6 days after transfer of unstimulated or CpG-stimulated peptide-pulsed DCs. All results representative of at lea...
<p>Diabetic mice received or not MSCs (A). Diabetic mice received or not insulin prophylaxis and/or ...
The Non-obese Diabetic Mouse (NOD) spontaneously develops diabetes with many similarities to the hum...
<p>Mice were infused intravenously on days 0 and 2 with 10 μg gp33–41, 10 μg gp276–286, 2 μg gp61–80...
<p>(A-H) Bone marrow derived DCs were matured with 10 μM CpG ODN 1826 and pulsed with the indicated ...
<p>Bone marrow derived DC were generated and cultured overnight in media with or without CpG ODN 182...
<p>(A) BMDC prepared from NOD mice (A) were incubated with vehicle, 1Z1 (0.4 and 2 μM) or LPS (100ng...
<p>Mice were infused intravenously with indicated peptides and adjuvants on days 0 and 2 and blood w...
In an effort to study the development of diabetes in NOD mice, our laboratory developed a novel adop...
<p>Representative pancreatic islets from RIP-OVA mice given TMEV-wt (A) or TMEV-L/OVA (B) without OT...
International audienceIn recent years, several investigators have shown that transfer of dendritic c...
We and others have previously demonstrated that treatment with bone marrow derived DC genetically mo...
Tolerogenic DCs (tolDCs) are being researched as a promising intervention strategy also in autoimmun...
<p>At day 130 after diabetes induction, pancreatic islets were observed (A) and quantified (B) in se...
We and others have previously demonstrated that treatment with bone marrow derived DC genetically mo...
<p>Diabetic splenocytes (1×10<sup>7</sup>) were co-transferred with or without CD4<sup>+</sup>CD25<s...
<p>Diabetic mice received or not MSCs (A). Diabetic mice received or not insulin prophylaxis and/or ...
The Non-obese Diabetic Mouse (NOD) spontaneously develops diabetes with many similarities to the hum...
<p>Mice were infused intravenously on days 0 and 2 with 10 μg gp33–41, 10 μg gp276–286, 2 μg gp61–80...
<p>(A-H) Bone marrow derived DCs were matured with 10 μM CpG ODN 1826 and pulsed with the indicated ...
<p>Bone marrow derived DC were generated and cultured overnight in media with or without CpG ODN 182...
<p>(A) BMDC prepared from NOD mice (A) were incubated with vehicle, 1Z1 (0.4 and 2 μM) or LPS (100ng...
<p>Mice were infused intravenously with indicated peptides and adjuvants on days 0 and 2 and blood w...
In an effort to study the development of diabetes in NOD mice, our laboratory developed a novel adop...
<p>Representative pancreatic islets from RIP-OVA mice given TMEV-wt (A) or TMEV-L/OVA (B) without OT...
International audienceIn recent years, several investigators have shown that transfer of dendritic c...
We and others have previously demonstrated that treatment with bone marrow derived DC genetically mo...
Tolerogenic DCs (tolDCs) are being researched as a promising intervention strategy also in autoimmun...
<p>At day 130 after diabetes induction, pancreatic islets were observed (A) and quantified (B) in se...
We and others have previously demonstrated that treatment with bone marrow derived DC genetically mo...
<p>Diabetic splenocytes (1×10<sup>7</sup>) were co-transferred with or without CD4<sup>+</sup>CD25<s...
<p>Diabetic mice received or not MSCs (A). Diabetic mice received or not insulin prophylaxis and/or ...
The Non-obese Diabetic Mouse (NOD) spontaneously develops diabetes with many similarities to the hum...
<p>Mice were infused intravenously on days 0 and 2 with 10 μg gp33–41, 10 μg gp276–286, 2 μg gp61–80...